Purchases and Sales Made in Q1 2023 in Chemomab Therapeutics Ltd. (CMMB)
This table provides information about the institutional ownership of Chemomab Therapeutics Ltd. (CMMB) during Q1 2023. The information is specifically focused on institutions that hold shares of Chemomab Therapeutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
30.3KNew |
$43.6K - $89K
|
30.3K
$55.1K
|
|
|
May 15, 2023
Q1 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
BUY
|
- |
11.8KNew |
$17K - $34.7K
|
11.8K
$21.5K
|
|
|
May 15, 2023
Q1 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
1.2K+ 18.18% |
$1.73K - $3.53K
|
7.8K
$14.2K
|
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 12, 2023
Q1 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-3.65K- 57.25% |
$5.25K - $10.7K
|
2.73K
$4.96K
|
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
SELL
|
- |
-4.22K- 91.12% |
$6.07K - $12.4K
|
411
$748
|
|
|
May 15, 2023
Q1 2023
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-25.1K- 48.6% |
$36.1K - $73.7K
|
26.5K
$48.3K
|
|
|
May 15, 2023
Q1 2023
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-76.7K- 24.47% |
$110K - $225K
|
237K
$431K
|
|
|
May 15, 2023
Q1 2023
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-337K- 13.07% |
$485K - $990K
|
2.24M
$4.08M
|